Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. It specializes in therapeutic antibodies, small molecule drugs, therapeutic nucleic acids, and regenerative medicine. The company was formed as a result of a merger between Kyowa Hakko and Kirin Pharma.